Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

General Electric Company (GE) Stock Needs Immelt to Step Down

General Electric (GE) CEO Jeffrey Immelt has been a fine steward, but the best thing for GE stock now would be a management shakeup.

Intel Corporation (INTC) Buys Mobileye NV (MBLY) to Win the Auto Market

Intel's (INTC) purchase of Mobileye (MBLY) is yet another sign that the auto market is as uncertain as it has been in the past century.

Toronto-Dominion Bank (TD) Hit by Claims it Pressured Employees to Lie

TD Bank shares took their biggest hit in years Friday as it was revealed that the company has high revenue goals practices that may be unethical.

BP plc (ADR) (BP) Stock Pops on Exxon Mobil Corporation (XOM) Takeover Rumors

BP stock was up on Friday on rumors that American company Exxon Mobil (XOM) is planning to take over the British company.

3 Earnings Reports Every Investor Should Watch Next Week

As the slate of earnings reports runs dry, there are still a few companies slated to release their numbers in the next week.

Microsoft Corporation (MSFT) Is More Expensive Than Alphabet Inc (GOOGL)

Microsoft (MSFT) has become the leader in enterprise cloud applications, the next big thing. Alphabet (GOOGL) has some catching up to do.

Ulta Beauty Inc (ULTA) Rebounds After Great Q4 Earnings

Ulta Beauty (ULTA) reported a solid Q4 on Thursday in which comps exploded by 17%. The bears bit ULTA stock first, but the bulls are winning.

Rite Aid Corporation (RAD) vs Walgreens Boot Alliance Inc (WBA)

RAD stock is tempting because of the possible Walgreens (WBA) merger. But betting on Rite Aid stock is still a huge risk.

3 Short Squeeze Stocks That Are Ready to Fly MUCH Higher

VeriFone Systems (PAY), Carnival Corp (CCL) and Valley National (VLY) are set for a short squeeze, as short interest in these stocks could send them soaring soon.

Tailored Brands Inc (TLRD) Tumbles Hard on Lousy Q4

Tailored Brands (TLRD) shares fell more than 30% as the company posted fiscal fourth-quarter results that missed the mark by quite a margin.

Lowe’s Companies, Inc. (LOW) Stock Not Worth the Premium

Lowe's is a well-run chain, but are its earnings really worth 25% more than those of rival Home Depot? No, avoid LOW stock for now.

E.l.f. Beauty Inc (ELF) Stock Skyrockets on Q4 Earnings Beat

E.l.f. Beauty (ELF) stock was flying high on Thursday following a positive earnings report for the fourth quarter of 2016.

Lululemon Athletica Inc. (LULU) Stock: Love on a Battlefield

Lululemon hopes to grow margins in 2017 but faces an aging population, and LULU stock faces analyst skepticism.

Stratasys, Ltd. (SSYS) Stock Plunges on 2017 Outlook

Stratasys (SSYS) stock was down on Thursday on a poor outlook for 2017 in its earnings report for the fourth quarter of 2016.

Should You Buy BlackBerry Ltd (BBRY) Stock? 3 Pros, 3 Cons

BBRY stock hasn't done anything for the last five years. Bulls tout 2017 as the year things finally change for BlackBerry, but don't overlook the risks.

Are These 5 Trump Stocks Worth the Trouble?

Donald Trump's defense and infrastructure spending should help plenty of companies, but may not be enough to make these Trump stocks a buy.

Why H & R Block Inc (HRB) Stock Is Surging Today

H&R Block (HRB) shares skyrocketed Wednesday as the company posted fiscal third-quarter results that topped Wall Street's expectations Tuesday.

Ciena Corporation (CIEN) Stock Sinks on Q1 Earnings Miss

Ciena (CIEN) stock was down on Wednesday after the company released a poor earnings report for its fiscal first quarter of 2017.

Global Blood Therapeutics Inc (GBT) Stock Soars on Takeover Talk

Global Blood Therapeutics (GBT) stock is rising as the company is being targeted for a takeover by another pharma corporation. Here's what's happenig